top of page
The purpose of this webpage and subsequent document is to provide information to existing and prospective investors, and potential commercial partners, about the current status of BCAL’s research and development. It is not intended to promote the use or supply of any therapeutic goods.
Research report: MST Access updates BCAL coverage
14 December, 2022
bottom of page